BANGKOK – Thailand's prime minister received a shot of the COVID-19 vaccine manufactured by AstraZeneca on Tuesday, as much of Asia shrugged off concerns about reports of blood clots in some recipients in Europe, saying that so far there is no evidence to link the two.
AstraZeneca has developed a manufacturing base in Asia, and the Serum Institute of India, the world’s largest vaccine maker, has been contracted by the company to produce a billion doses of the vaccine for developing nations.
Hundreds of millions more are to be manufactured this year in Australia, Japan, Thailand and South Korea. “There are people who have concerns," Thai Prime Minister Prayuth Chan-ocha said after he received the first dose of the AstraZeneca vaccine. "But